- Elevated Vacancy Persists:
Overall vacancy remained far above historical averages, and at 14.3% is more than 500 basis points higher than at the same point one year ago. Cambridge remains the market’s tightest geographic cluster at 8.5% vacant, though this represents an increase of 210 basis points QOQ. - Demand Slows QOQ:
Following the pattern of other asset types, the lab market was quiet during Q2 as new demand totaled just over 305,000 sf – less than one third of Q1’s leasing total. - Robust Pipeline; Slow Preleasing:
Preleasing in under-construction inventory remained sluggish with just 35.3% of the nearly 15.0 msf currently in development committed. Of the 5.8 msf scheduled to deliver before the remainder of 2023, just 36.3% has been leased. - Traditional Clusters Remain Dominant:
Of the 54 users currently seeking space in the market, more than half are focused on Cambridge. - Leader in Venture Capital Investment:
With $3.5B invested YTD, interest in Greater Boston has outpaced all other major North American markets in 2023.
Boston Life Science Five Fast Facts Q2 2023
Riley McMullan • 7/28/2023
Related Insights

Article
Does your building qualify for a life sciences conversion?
Interest in converting assets for life sciences use is growing amongst building owners. Cushman & Wakefield’s Project & Development Services team developed basic building performance criteria based on the minimum standards that life sciences companies typically require.
Eric Giles • 7/18/2023

MarketBeat
Cushman & Wakefield MarketBeat reports analyze quarterly economic and commercial real estate activity including supply, demand and pricing trends at the market and submarket levels.
Riley McMullan • 7/17/2023

Research
Life Sciences Update: March 2023
Accelerated growth in the life sciences sector has translated into double-digit rent growth, single-digit vacancy rates, and strong investment flows in the last ten years.
Sandy Romero • 3/20/2023